← Back to Search

Carotenoid

Astaxanthin for Healthy Subjects

N/A
Waitlist Available
Led By Shoná Burkes-Henderson, PhD
Research Sponsored by LycoRed Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 and 12 weeks
Awards & highlights

Summary

This trial will test the effects of a specific nutritional supplement on indicators of overall health, including markers of inflammation, oxidative stress, and levels of lipids and blood flow. The study will also assess the impact of the supplement on skin condition, mood, and longevity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To assess the effect of Astaxanthin on oxidative stress within the group and compared to placebo
Secondary outcome measures
To assess the effect of the Astaxanthin on blood flow within the group and compared to placebo
To assess the effect of the Astaxanthin on facial skin hydration within the group and compared to placebo
To assess the effect of the Astaxanthin on inflammation within the group and compared to placebo
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AstaxanthinExperimental Treatment1 Intervention
Active Ingredient: Astaxanthin Inactive ingredients: Modified food starch, sucrose, water, sodium ascorbate, DL- alpha tocopherols
Group II: PlaceboPlacebo Group1 Intervention
Modified food starch, sucrose, hylocereus polyrhizus (pitaya) concentration
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Astaxanthin
2014
Completed Phase 3
~380

Find a Location

Who is running the clinical trial?

LycoRed Ltd.Lead Sponsor
12 Previous Clinical Trials
642 Total Patients Enrolled
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.NETWORK
34 Previous Clinical Trials
1,922 Total Patients Enrolled
Shoná Burkes-Henderson, PhDPrincipal InvestigatorSGS Stephens, Inc
~19 spots leftby Jul 2025